In our own work, we observed that MDS patients without altered monocyte morphology or cytogenetic abnormalities, but with a high percentage of monocytes with (abnormal) increased CD56 expression, exhibit functional alterations (unpublished data). The gene discussed is NCAM1; the disease is myelodysplastic syndrome.